Características microbiológicas de infecciones en pacientes pediátricos con cáncer del eje cafetero colombiano, 2014-2016
DOI:
https://doi.org/10.35839/repis.6.3.1456Palabras clave:
neoplasms, nosocomial infection, pediatrics, cancer care facilities, antibioticsResumen
Objective: To describe microbiological characteristics of infections in pediatric patients with cancer in a reference center of the Colombian coffee region, 2014-2016. Materials and methods. Cross-sectional, descriptive study including underaged oncological inpatients managed in a reference institution in Colombia; who have been dated an infection with a subsequent antibiogram done. The collection sheet validated by experts is reported through WHONET 5.6. Descriptive statistical analyzes were performed with STATA 14.2, official version. Results. 2691 cultures from 596 patients were included. 53.86% were male, the mean age was 8.86 years. 76.89% of the cultures were performed in the hospitalization area. 74.36% of the cultures were blood, with 22.04% positive reports. The second sample with the highest number of cultures was urine with 16.16%, with 25.75% positive cultures. The highest percentage of positive cultures was for feces and biopsies with 71.21% and 53.13%, respectively. An overall positivity rate of 25.75% was presented. The three main microorganisms isolated were Gram negative. The most isolated microorganisms were K. pneumoniae (24.4%), E. coli (21.06%) and P. aeruginosa (17.46%). Conclusion. Infection pattern similar to the one reported in adults, being the Gram-negatives the most prevalent agents. We recommend establishing antibiotic dispensing policies thus achieving microbiological risk control and improving epidemiological surveillance.
Descargas
Citas
Cataño-Toro D, Marín-Medina DS, Rivera J, Martínez JW, Sánchez-Duque JA, Martínez-Muñoz MA, et al. Neutropenia febril asociada a quimioterapia en pacientes con neoplasias hematológicas de un centro de referencia en Colombia: características clínicas y desenlaces. Salud, Barranquilla. 2019; 35(2): 205-20. doi: 10.14482/sun.35.2.616.15
Martínez JW, Martínez Muñoz MA, López Osorio JJ, Marín Medina DS, Orozco Hernández JP, Sosa Urrea JD, Sánchez Duque JA. Factores de riesgo para mortalidad en la infección por Pseudomonas aeruginosa en pacientes oncológicos hospitalizados en tres ciudades de Colombia. MedUNAB [Internet]. 2017 [citado 30 de abril de 2022]; 20(1): 39-47. Disponible en: https://revistas.unab.edu.co/index.php/medunab/article/view/2666.
Moskalewicz RL, Isenalumhe LL, Luu C, Wee CP, Nager AL. Bacteremia in non neutropenic pediatric oncology patients with central venous catheters in the ED. Am J Emerg Med. 2017; 35(1): 20-4. doi: 10.1016/j.ajem.2016.09.028.
Bailey LC, Reilly AF, Rheingold SR. Infections in pediatric patients with hematologic malignancies. Semin Hematol. 2009;46(3):313–24. doi: 10.1053/j.seminhematol.2009.03.010
Biwersi C, Hepping N, Bode U, Fleischhack G, von Renesse A, Exner M, et al. Bloodstream infections in a German paediatric oncology unit: prolongation of inpatient treatment and additional costs. Int J Hyg Environ Health. 2009; 212(5): 541–6. doi: 10.1016/j.ijheh.2009.01.003
Mvalo T, Eley B, Bamford C, Stanley C, Chagomerana M, Hendricks M, et al. Bloodstream infections in oncology patients at Red Cross War Memorial Children's Hospital, Cape Town, from 2012 to 2014. Int J Infect Dis. 2018; 77: 40–7. doi: 10.1016/j.ijid.2018.09.012
Martínez JW, Gutiérrez-Ocampo E, Valencia-Arango D, Henao-Martínez JF, Sánchez-Duque JA. Microbiological characteristics of infections in a group of colombian patients with oncological diagnosis, 2014 – 2016. Infectio. 2020;24(3):182. doi: 10.22354/in.v24i3.864
Yoshida H, Leger KJ, Xu M, Migita RT, Rutledge JC, Pollard JA, et al. Improving time to antibiotics for pediatric oncology patients with suspected infections: An emergency department–based quality improvement intervention. Pediatr Emerg Care. 2018;34(1):47–52. doi: 10.1097/PEC.0000000000001367
Qureshi S, Fatima P, Mukhtar A, Zehra A, Qamar FN. Clinical profile and outcome of antibiotic lock therapy for bloodstream infections in pediatric hematology/oncology patients in a tertiary care hospital, Karachi, Pakistan. Int J Pediatr Adolesc Med. 2019;6(1):25–8. doi: 10.1016/j.ijpam.2019.01.004
Costa P de O, Atta EH, Silva ARA da. Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes. J Pediatr (Rio J). 2015; 91(5): 435–41. doi: 10.1016/j.jped.2014.11.009
Ammann RA, Laws HJ, Schrey D, Ehlert K, Moser O, Dilloo D, et al. Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors. Eur J Pediatr. 2015; 174(5): 675–86. doi: 10.1007/s00431-015-2525-5
El-Mahallawy HA, Hassan SS, El-Wakil M, Moneer MM. Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients. J Egypt Natl Canc Inst. 2016; 28(3): 157–62. doi:
1016/j.jnci.2016.05.002
Cortés J, Cuervo S, Arroyo P, Quevedo R. Hallazgos microbiológicos en pacientes con neutropenia febril. Rev Colomb Cancerol [Internet]. 2003 [citado el 30 de abril de 2022]; 7 (4): 5-11. Disponible en: https://www.revistacancercol.org/index.php/cancer/article/view/644
Gómez-González JF, Sánchez-Duque JA. Perfil microbiológico y resistencia bacteriana en una unidad de cuidados intensivos de Pereira, Colombia, 2015. Rev médicas UIS. 2018; 31(2): 9–15. doi: 10.18273/revmed.v31n2-2018001
Tsai H-C, Huang L-M, Chang L-Y, Lee P-I, Chen J-M, Shao P-L, et al. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy. J Microbiol Immunol Infect. 2015; 48(6): 639–46. doi: 10.1016/j.jmii.2014.07.008
Arias D, Romero H, Domínguez MC, Guzmán M, Mendoza AE. Caracterización de los pacientes con infección tardía del torrente sanguíneo en la Unidad Neonatal del Hospital de San José entre junio de 2014 y mayo de 2015. Serie de casos. Repert Med Cir. [Internet]. 2016 [citado 15 de mayo de 2021]; 25 (4): 252-7. Disponible en: https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/107
Santolaya ME, Contardo V, Torres JP, López-Medina E, Rosanova MT, Álvarez AM, et al. Manejo de los episodios de neutropenia febril en niños con cáncer. Consenso de la Sociedad Latinoamericana de Infectología Pediátrica 2021. Rev chil infect. 2021; 38 (6): 857-909. doi: 10.4067/s0716-10182021000600857
Bello-Suárez AK, Cuesta-Armesto MH, Díaz-Rojas MJ, Mendoza-Uribe Leidy, Sarmiento-Wilches PE. Microbiological characterization and antimicrobial susceptibility pattern of infections associated with febrile neutropenia in pediatric hemato-oncological patients. Andes pediátr. 2022; 93 (1), 65-77. doi: 10.32641/andespediatr.v93i1.3629
Rodriguez-Morales A, Martinez-Pulgarin DF, Muñoz-Urbano M, et al. (May 01, 2017) Bibliometric Assessment of the Global Scientific Production of Nitazoxanide. Cureus 9(5): e1204. doi:
7759/cureus.1204
Hernández-Negrete EL, Ruilova-Gavilanes KM, Bravo-Galarza IP, Ortiz-Pineda TA. Neutropenia Febril en Pacientes Oncológicos Pediátricos. RECIAMUC. 2021; 5 (1): 130-139. doi:
26820/reciamuc/5.(1).ene.2021.130-139
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2022 Mariana Blanco-Betancur, José W. Martínez, Daniela M. Patiño-Galarza, Laura K. Gil-Lopez, Nasly J. Ochoa-Zapata, Jorge A. Sánchez-Duque
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
